Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells
Authors
Keywords
Breast cancer, Aromatase inhibitor resistance, Aurora kinases, Kinase inhibitors, Cell cycle
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 149, Issue 3, Pages 715-726
Publisher
Springer Nature
Online
2015-04-22
DOI
10.1007/s10549-015-3284-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
- (2015) STINE HOLE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
- (2015) Shuying Liu et al. Oncotarget
- Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
- (2013) Susan Thrane et al. BREAST CANCER RESEARCH AND TREATMENT
- Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
- (2013) Per Eystein Lønning et al. ENDOCRINE-RELATED CANCER
- The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
- (2012) Julia A Beaver et al. Future Oncology
- Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
- (2011) M. G. Manfredi et al. CLINICAL CANCER RESEARCH
- Aromatase, aromatase inhibitors, and breast cancer
- (2011) Saranya Chumsri et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- ER -Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer
- (2011) T. W. Miller et al. Cancer Discovery
- Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
- (2010) Christopher P Gully et al. Molecular Cancer
- Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
- (2010) A. A. Dar et al. MOLECULAR CANCER THERAPEUTICS
- Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780
- (2009) Jayasree S. Nair et al. MOLECULAR BIOLOGY OF THE CELL
- Structural basis for androgen specificity and oestrogen synthesis in human aromatase
- (2009) Debashis Ghosh et al. NATURE
- Genome-Wide Analysis of Aromatase Inhibitor-Resistant, Tamoxifen-Resistant, and Long-Term Estrogen-Deprived Cells Reveals a Role for Estrogen Receptor
- (2008) S. Masri et al. CANCER RESEARCH
- The regulatory β-subunit of protein kinase CK2 regulates cell-cycle progression at the onset of mitosis
- (2008) C W Yde et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started